BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Disulfiram

A carbamate derivative used as an alcohol deterrent. It is a relatively nontoxic substance when administered alone, but markedly alters the intermediary metabolism of alcohol. When alcohol is ingested after administration of disulfiram, blood acetaldehyde concentrations are increased, followed by flushing, systemic vasodilation, respiratory difficulties, nausea, hypotension, and other symptoms (acetaldehyde syndrome). It acts by inhibiting aldehyde dehydrogenase.

297+ PubMed studies analyzed · 9 RCTs · Evidence Score: 41.7

Research Domains

Disulfiram has been studied across 10 research domains including 🫁 Liver & Detox, 🌤️ Mood & Depression, 🧠 Focus & Attention, 🔬 Oncology, ❤️ Cardiovascular. The primary research focus is 🫁 Liver & Detox with 12% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Disulfiram, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Nisoldipine
53 shared targets
Daunorubicin
46 shared targets
Chlorhexidine
50 shared targets
Hexachlorophene
60 shared targets
Perphenazine
43 shared targets
Emodin
41 shared targets
Ethinyl
40 shared targets
tyrphostin
36 shared targets
Astemizole
51 shared targets
Clotrimazole
50 shared targets
Loading evidence profile...

This evidence profile for Disulfiram is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.